Looks good from initial observations...
Revenue and earnings growth ahead of plan
2 0 2 4 I N T E R I M R E S U L T S
5
Key financials
• Interim result ahead of Company plan- Revenue growth of 3.7% to $812.1 million- EBITDA up 5.0% to $113.2 million with an EBITDA margin of 13.9%
(up 0.2ppts)- Net profit after tax (NPAT) attributable to owners of the Company up 15.6%
to $85.3 million1- Basic earnings per share (EPS) up 18.6% to 11.8 cents- Closing net cash2 of $792.1 million up $34.9 million on June 2023 with
operational cash conversion of 86.8%3
• Revenue growth driven by China segment (China label + CBEC)- China & Other Asia segment sales up 16.5%, ANZ sales down 24.1%
due to a change in distribution strategy, USA sales up 8.6% and MVM sales
down 4.7%- Total IMF sales up 1.5% with China label sales up 10.4% and English label
sales down 6.9%- Liquid milk sales in ANZ and USA up 1.5% and 7.0% respectively- Other nutritionals up 48.5%
- Forums
- ASX - Day Trading
- Day traders' after-market lounge May 1
Day traders' after-market lounge May 1, page-23
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online